[
    [
        {
            "time": "2019-06-04",
            "original_text": "监管局查账 77 家药企！销售费用 Top20 企业有 7 个",
            "features": {
                "keywords": [
                    "监管局",
                    "查账",
                    "药企",
                    "销售费用"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "监管局查账 77 家药企！销售费用 Top20 企业有 7 个",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-06-04",
            "original_text": "一个都不能少！强监管“排雷”，这类股被资金抛弃",
            "features": {
                "keywords": [
                    "强监管",
                    "排雷",
                    "资金抛弃"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "一个都不能少！强监管“排雷”，这类股被资金抛弃",
                "Correlation": 7,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-06-04",
            "original_text": "医药行业迎来1个月的检查工作，销售费用成重点",
            "features": {
                "keywords": [
                    "医药行业",
                    "检查工作",
                    "销售费用"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业迎来1个月的检查工作，销售费用成重点",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-06-04",
            "original_text": "财政部检查77家药企会计信息：27家A股、1家港股和3家美股或受影响",
            "features": {
                "keywords": [
                    "财政部",
                    "检查",
                    "药企",
                    "会计信息"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "财政部检查77家药企会计信息：27家A股、1家港股和3家美股或受影响",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-06-04",
            "original_text": "医药板块受冲击？财政部将检查77家药企销售费用，实行“穿透式”监管，多家明星药企在列",
            "features": {
                "keywords": [
                    "医药板块",
                    "冲击",
                    "财政部",
                    "检查",
                    "销售费用",
                    "穿透式监管"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药板块受冲击？财政部将检查77家药企销售费用，实行“穿透式”监管，多家明星药企在列",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-06-04",
            "original_text": "医药股普跌 医药行业会计信息质量检查正在进行",
            "features": {
                "keywords": [
                    "医药股",
                    "普跌",
                    "会计信息质量检查"
                ],
                "sentiment_score": -0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药股普跌 医药行业会计信息质量检查正在进行",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-06-04",
            "original_text": "财政部开展2019年度医药行业会计信息质量检查工作 多家上市公司在列",
            "features": {
                "keywords": [
                    "财政部",
                    "医药行业",
                    "会计信息质量检查",
                    "上市公司"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "财政部开展2019年度医药行业会计信息质量检查工作 多家上市公司在列",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-06-04",
            "original_text": "寿仙谷抗癌逾红线：核心产品毛利率93% 销售费用猛涨",
            "features": {
                "keywords": [
                    "寿仙谷",
                    "抗癌",
                    "毛利率",
                    "销售费用"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "寿仙谷抗癌逾红线：核心产品毛利率93% 销售费用猛涨",
                "Correlation": 7,
                "Sentiment": 2,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]